MicroBiome Therapeutics, LLC, a biotechnology company, develops medical food and pharmaceutical products. The company focuses on developing evidence-based microbiome modulators, which are designed to alter bacteria populations and their environment in the gastrointestinal tract in specific ways to treat and prevent serious health conditions. Its product includes NM504, which contains a combination of prebiotic and other naturally occurring ingredients formulated to help diabetic individuals achieve healthy blood glucose levels and manage their body weight. MicroBiome Therapeutics, LLC was formerly known as NuMe Health LLC. The company was founded in 2009 and is based in Broomfield, Colorado.
New Orleans, US
Size (employees)
6 (est)
Microbiome Therapeutics was founded in 2009 and is headquartered in New Orleans, US
Report incorrect company information

Key People/Management at Microbiome Therapeutics

Mark Heiman

Mark Heiman


Microbiome Therapeutics Office Locations

Microbiome Therapeutics has an office in New Orleans
New Orleans, US (HQ)
1316 Jefferson Ave
Show all (1)
Report incorrect company information

Microbiome Therapeutics Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$1.3 m

Latest funding size

$743.45 k

Time since last funding

3 years ago


Microbiome Therapeutics's latest funding round in June 2015 was reported to be $743.5 k. In total, Microbiome Therapeutics has raised $1.3 m
Report incorrect company information

Microbiome Therapeutics News and Updates

Microbiome Therapeutics Market Analysis, Market Size, Regional Outlook, Competitive Strategies and Forecasts, 2017 To 2022, Focusing On Top Key C3 Jian, Enterome Bioscience, Immuron, MicroBiome Therapeutics, OpenBiome, Osel, Ritter Pharmaceuticals

This report studies Microbiome Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. Posted via Industry Today. Follow us on Twitt…

Microbiome Therapeutics Market Dynamics, Segments and Supply Demand 2017 – 2027

Future Market Insights has announced the addition of the “Microbiome Therapeutics Market Global Industry Analysis and Opportunity Assessment, 2017-2027"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information